Simplex Trading’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-481,048
| Closed | -$2.54M | – | 3830 |
|
2025
Q1 | $2.54M | Buy |
481,048
+217,676
| +83% | +$1.15M | ﹤0.01% | 177 |
|
2024
Q4 | $1.78M | Sell |
263,372
-21,341
| -7% | -$144K | ﹤0.01% | 296 |
|
2024
Q3 | $1.88M | Buy |
284,713
+189,941
| +200% | +$1.25M | ﹤0.01% | 286 |
|
2024
Q2 | $710K | Buy |
94,772
+58,556
| +162% | +$439K | ﹤0.01% | 535 |
|
2024
Q1 | $361K | Buy |
+36,216
| New | +$361K | ﹤0.01% | 763 |
|
2023
Q4 | – | Sell |
-84,110
| Closed | -$643K | – | 3825 |
|
2023
Q3 | $643K | Buy |
84,110
+82,693
| +5,836% | +$632K | ﹤0.01% | 470 |
|
2023
Q2 | $10K | Buy |
1,417
+494
| +54% | +$3.49K | ﹤0.01% | 1766 |
|
2023
Q1 | $6K | Sell |
923
-482
| -34% | -$3.13K | ﹤0.01% | 1865 |
|
2022
Q4 | $10K | Sell |
1,405
-1,370
| -49% | -$9.75K | ﹤0.01% | 1835 |
|
2022
Q3 | $29K | Buy |
+2,775
| New | +$29K | ﹤0.01% | 1618 |
|
2022
Q2 | – | Sell |
-397
| Closed | -$2K | – | 3996 |
|
2022
Q1 | $2K | Sell |
397
-485
| -55% | -$2.44K | ﹤0.01% | 2636 |
|
2021
Q4 | $15K | Sell |
882
-6,084
| -87% | -$103K | ﹤0.01% | 2317 |
|
2021
Q3 | $250K | Sell |
6,966
-100
| -1% | -$3.59K | ﹤0.01% | 1201 |
|
2021
Q2 | $257K | Buy |
+7,066
| New | +$257K | ﹤0.01% | 1201 |
|